Study Designs in Medical Research

← Back to Index (πŸ”’ Statistics)

Overview of Biomedical Study Designs

Observational Study Designs

Study Type Description and Methodology Key Advantages Key Disadvantages Measure of Association
Cross-Sectional Study Data are collected from a sample at a single, defined point in time (a "snapshot"). Quick, inexpensive, easy to perform, and has no loss to follow-up. Useful for determining the point prevalence of conditions. Cannot determine a temporal sequence, making it impossible to establish causality. Not suitable for rare diseases. Prevalence.
Case-Control Study A retrospective design where patients with a disease (cases) are compared to those without the disease (controls) regarding past exposure to suspected risk factors. Highly efficient and inexpensive for studying rare diseases or diseases with long latent periods. Prone to recall bias and observer bias when ascertaining past exposures. Cannot yield estimates of true disease incidence or prevalence. Odds Ratio (OR).
Cohort Study Follows disease-free exposed and unexposed groups forward in time to observe who develops the outcome of interest. Can be prospective or retrospective. Establishes a clear temporal sequence, providing stronger evidence for causality. Valuable for studying rare exposures and calculating true incidence. Expensive, time-consuming, requires a large sample size, and is highly vulnerable to attrition or loss to follow-up. Relative Risk (RR) or Incidence.

Cross-Sectional Studies

Case-Control Studies

Cohort Studies

Ecological Studies

Experimental and Interventional Study Designs

Trial Design Description and Application
Parallel Design The most common clinical trial design where each patient is randomized to receive only one type of treatment (e.g., Treatment A or Treatment B) and the groups are studied concurrently.
Crossover Design Each participant receives both the control and the intervention in a randomized sequence (e.g., Drug A then Drug B, or vice versa). Patients serve as their own controls, requiring fewer subjects. A washout period is necessary to minimize carry-over effects from the first treatment.
Factorial Design Tests the effect of more than one treatment simultaneously. In a 2x2 design, subjects are divided into groups receiving neither treatment, only A, only B, or both A and B, allowing researchers to evaluate the individual effects and potential interactions between the treatments.
Cluster Randomized Trial Groups or clusters of individuals (such as families, geographical areas, or hospital wards) are randomly allocated to the intervention groups instead of randomizing individuals. Often used to avoid treatment contamination or for administrative convenience.
Non-inferiority Trial Designed to prove that a new drug is no worse (by a pre-specified margin) than a current standard treatment.
Equivalence Trial Aims to determine whether one intervention is therapeutically similar (neither significantly better nor worse within a defined margin) to another existing treatment.

Parallel Randomized Controlled Trials (RCT)

Crossover Trials

Factorial Design Trials

Cluster Randomized Trials

Quasi-Experimental Studies